B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA (B-NHL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA (B-NHL) trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA (B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dual-Target CAR t cells offer new hope for tough lymphoma
Disease control Recruiting nowThis early-phase trial tests a new type of immunotherapy called CD19x22 CAR T cells in people aged 16 and older with B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. The therapy uses the patient's own immune cells, modified to attack two targets on ca…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for tough lymphoma: experimental drug takes on standard care in major trial
Disease control Recruiting nowThis study tests an experimental drug called odronextamab for people with aggressive B-cell non-Hodgkin lymphoma whose cancer has returned or no longer responds to treatment. About 216 participants will receive either the new drug or standard therapy to compare safety, effectiven…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:53 UTC